CVS Health(US:CVS)2025-07-31 12:00Financial Performance & Guidance - CVS Health reported consolidated revenue growth of 8.4% in the second quarter of 2025[6] - Adjusted EPS for Q2 2025 was $1.81[6, 7, 11] - The company raised its 2025 adjusted EPS guidance to a range of $6.30 to $6.40[6, 14] - Full year 2025 consolidated revenue is projected to be at least $391.5 billion[7, 13] - Full year 2025 adjusted operating income is expected to be between $13.77 billion and $13.94 billion[7, 13] - Cash flow from operations for full year 2025 is projected to be at least $7.5 billion[7, 13] Segment Performance - Health Care Benefits total revenues for Q2 2025 were $36.3 billion[18] - Health Care Benefits adjusted operating income increased by nearly 40% year over year in Q2 2025[19] - Health Services total revenues for Q2 2025 were $46.5 billion[21] - Health Services adjusted operating income decreased ~18% year over year in Q2 2025[22] - Pharmacy & Consumer Wellness total revenues for Q2 2025 were $33.6 billion[24] - Pharmacy & Consumer Wellness adjusted operating income increased nearly 8% year over year in Q2 2025[25]